SCHEMBL21896283

SCHEMBL21896283

C=C1CCCc2c(nc(OC[C@@H](C)CCCC)nc2N(CCC)CC(C)CC#N)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21912184 0.90 — —
SCHEMBL21912768 0.82 — —
SCHEMBL25021702 0.74 — —
SCHEMBL21896256 0.74 — —
SCHEMBL21846275 0.74 — —
SCHEMBL25021351 0.67 — —
SCHEMBL21895575 0.66 — —
SCHEMBL21912130 0.66 KRAS (0.36) —
SCHEMBL22087290 0.66 KRAS (0.36) —
SCHEMBL25020009 0.66 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020055756-A1 COMBINATION THERAPIES Mirati Therapeutics, Inc. (US) 2020-03-19 — — WO disclosed
Send feedback